Zehra Gül Morçimen

Zehra Gül Morçimen

Auto-generated profile, based on publicly available information

Zehra Gül Morçimen

Department of Bioengineering, Graduate School of Natural and Applied Sciences, Ege University, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2025 in Biomaterials
Verified
Journal Article
Open access
Rohollah NasiriRohollah Nasiri
Rohollah Nasiri
MMMasoud Madadelahi
Masoud Madadelahi
MNMohammad Reza Nikmaneshi
Mohammad Reza Nikmaneshi
BGBegum Gokce
Begum Gokce
MBMohamad Ali Bijarchi
Mohamad Ali Bijarchi
AHAnna Herland
Anna Herland
Replicating the in vitro properties of tissue barriers-such as the blood-brain barrier, gut, skin, lung, kidney, retina, nasal epithelium, and placenta-is crucial for many applications, including drug screening, studying molecular transport, drug delivery, and disease modeling in preclinical studies. Organ-on-a-chip (OoC) platforms are advanced three-dimensional (3D) in vitro models that aim to replicate various aspects of organ functionality within microfluidic systems by providing microenvironments akin to native tissue. When used to model the interface between two different tissue compartments, OoC technology offers a promising platform for more accurately replicating the physiology and pathophysiology of various tissue barriers in the body. This review focuses on the state-of-the-art biomimetic tissue barrier models, ranging from two-channel tissue barrier-on-a-chip systems with a thin porous membrane to hydrogel-based membrane models. Specifically, it explores the engineering of tissue barrier-on-a-chip platforms, highlighting various fabrication techniques for microfluidic chips and membranes, as well as methods for functional characterization of the engineered tissue barriers. Additionally, we discuss the development of organ-specific barrier models and multi-organ-on-a-chip systems for studying inter-organ communication. Finally, we highlight the current challenges in the field and future directions in advancing tissue barrier modeling using OoC technology.

25 February 2024 in Cellulose
Verified
Journal Article
Open access
PDF file
YÖYunus Emre Öz
Yunus Emre Öz
NBNur Deniz Bingül
Nur Deniz Bingül
ZMZehra Gül Morçimen
Zehra Gül Morçimen
ASAylin Sendemir
Aylin Sendemir
EHElif Esin Hameş
Elif Esin Hameş
Bacterial cellulose (BC) is a biomaterial extensively studied in tissue engineering due to its favorable properties. Porosity, biocompatibility, biodegradability and mechanical durability are essential material properties for scaffold use in tissue engineering. This study aims to fabricate porous scaffolds using a moldable and degradable BC-HAp composite for bone tissue engineering. BC was produced by Komagataeibacter sucrofermentans under static culture conditions. The harvested BC membranes were purified and then mechanically shredded. BC oxidation was performed using different sodium periodate concentrations (0.05–0.5 M) and treatment times (0.5–12 h). Oxidized BCs (oxBC) were modified with hydroxyapatite (HAp), then were moulded, lyophilized, and characterized. The degradability of the scaffolds was determined for 45 days. Cytotoxic analysis of oxBC scaffolds was carried out for 7 days using the L929 fibroblast cell line. The oxidation degrees of the shredded BC samples were between 6.75 and 81%, which increased in line with the increasing concentration and application time of periodate. The scaffolds prepared using oxidized cellulose for 30 and 60 min (oxBC30 and oxBC60) preserved their integrity, These scaffolds showed a weight loss of 9% and 14% in 45 days, respectively. The pore distribution was between 50 and 450 µm and concentrated in the 50–150 µm range. The compression moduli were 88.72 kPa and 138.88 kPa for oxBC30-HAp and oxBC60-HAp, respectively. It was determined that oxBC did not show a significant difference in cell viability compared to the control groups and was not cytotoxic. In conclusion, degradable and more porous bone scaffolds were fabricated using mouldable oxBC.

1 January 2019 in Materials Today: Proceedings
Verified
Journal Article
Closed access
ZMZehra Gül Morçimen
Zehra Gül Morçimen
ŞTŞeyma Taşdemir
Şeyma Taşdemir
ÇEÇağlar Erdem
Çağlar Erdem
FGFethullah Güneş
Fethullah Güneş
ASAylin Sendemir
Aylin Sendemir

21 August 2025 in Tarla Bitkileri Merkez Arastirma Enstitusu
Verified
Journal Article
Open access
PDF file
AMAyse Malbora
Ayse Malbora
MSMehmet Emin Senol
Mehmet Emin Senol
BSBusranur Senol
Busranur Senol
ZMZehra Gul Morcimen
Zehra Gul Morcimen
Nanofiber wound dressings are developed using various polymers and adding different active agents to the polymers during the production phase. In this study, PLGA, PLGA containing silver nanoparticles (AgNP/PLGA), PLGA nanofibers containing 1%, 2%, 3% licorice root, and silver nanoparticle doped (LR-AgNP/PLGA) were produced by electrospinning method. The green synthesis method was used to produce licorice-containing silver nanoparticles (LR-AgNP). The morphological analysis of nanofibers was determined using diameter measurements on SEM images. The average fiber diameters of PLGA, AgNP/PLGA, and LR-AgNP/PLGA nanofibers are 344 nm, 260 nm, and 357 nm, respectively. FTIR analysis was used for the determination of chemical bonds. The FTIR graph of PLGA, AgNP/PLGA and LR-AgNP/PLGA nanofibers showed similar peaks in the 3008-2883 cm-1, 1500-1412 cm-1, 1181-1086 cm-1 and 1755-1750 cm-1 bands. The wound healing potential of the produced nanofibers was evaluated on an in vitro wound scratch model. According to the results obtained, LR-AgNP/PLGA nanofibers showed the fastest wound closure. As a result of these studies, it was determined that PLGA nanofibers with silver nanoparticles containing licorice root extract could accelerate the wound healing process.

23 June 2023 in Hacettepe Journal of Biology and Chemistry
Verified
Journal Article
Closed access
EBEce Battaloğlu
Ece Battaloğlu
ZMZehra Gül Morçi̇men
Zehra Gül Morçi̇men
ASAylin Sendemir
Aylin Sendemir
Gliosis is a condition that plays a negative role in various neurological pathologies. In this study, it was aimed to obtain and compare the glio-protective effects of electrospun fibrous scaffolds coated by different biopolymers. First, in vitro gliosis model was obtained by inducing U-87 MG cells with LPS and IFN-γ. The optimized model was applied to U-87 MG cells grown on polycaprolactone (PCL), hyaluronic acid (HA) coated, gelatin coated, and collagen coated PCL scaffolds. Immunofluorescent (IF) staining was performed with glial fibrillary acidic protein (GFAP) antibody to determine the level of gliosis. It was found that 5µg/mL LPS concentration induced gliosis and hyaluronic acid-coated PCL scaffolds have shown a protective effect on gliosis.

5 March 2026 in Tarla Bitkileri Merkez Arastirma Enstitusu
Verified
Journal Article
Closed access
BŞBüşranur Şenol
Büşranur Şenol
AMAyşe Malbora
Ayşe Malbora
MŞMehmet Emin Şenol
Mehmet Emin Şenol
ZMZehra Gül Morçimen
Zehra Gül Morçimen
Electrospun nanofiber wound dressings potentially provide a highly suitable environment for healing compared to traditional wound dressings, which often fail to meet all the requirements of the wound healing process. This study aimed to develop PLGA nanofibers incorporating silver nanoparticles containing Echinacea extract for use as wound dressings; to perform their characterization tests, and evaluate their wound healing efficacy using in vitro models. Echinacea silver nanoparticles were synthesized using a green synthesis method. PLGA, silver nanoparticle containing PLGA (AgNP/PLGA), 1%, 2%, 3%, Echinacea silver nanoparticle containing PLGA (Ec-AgNP/PLGA) nanofibers were produced by electrospinning method. The nanofibers were characterized by SEM, FTIR, XRD and antibacterial analysis and evaluated using an in vitro wound scratch test. The average zone diameters of Ec-AgNP/PLGA nanofibers against the E. coli and S. aureus bacteria were found to be 13.5±0.3 mm. The antioxidant capacity analysis of the Echinacea extract used in the study was evaluated by the DPPH (2,2-diphenyl-1-picrylhydrazyl) method and the percentage of DPPH radical removal was calculated as 46.8% and the ascorbic acid equivalent was determined as 35.5 µM. The results demonstrated that Echinacea significantly accelerated wound healing due to its therapeutic and antioxidant properties.